🇺🇸 FDA
Pipeline program

Mifepristone 300 MG [Korlym]

C-1073-310

Approved small_molecule completed

Quick answer

Mifepristone 300 MG [Korlym] for Hypercortisolism is a Approved program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
CORCEPT THERAPEUTICS INC
Indication
Hypercortisolism
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials